UNSPSC 51132237: Aspirin/dihydroxyaluminum aminoacetate/magnesium carbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

UNSPSC 51132237 Aspirin/dihydroxyaluminum aminoacetate/magnesium carbonate is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The single recent opportunity identified under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, not antacid formulations. This misalignment suggests either a tagging error in the procurement database or that the code is not capturing its intended market activity.

The Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2023 (an inconsistency in the source data), seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit electronic bids including all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and agree to a two-year term with optional one-year renewal. The procurement may be FEMA-funded and subjects contractors to federal compliance requirements and audits. No other recent state or local opportunities appear under this code, limiting visibility into issuing-body patterns or geographic spread beyond this single Florida county purchase.